| ADAR1 mutation causes ZBP1-dependent immunopathology NW Hubbard, JM Ames, M Maurano, LH Chu, KY Somfleth, NS Gokhale, ... Nature 607 (7920), 769-775, 2022 | 112 | 2022 |
| An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye D Jaishankar, AM Yakoub, T Yadavalli, A Agelidis, N Thakkar, S Hadigal, ... Science translational medicine 10 (428), eaan5861, 2018 | 81 | 2018 |
| Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery T Yadavalli, J Ames, A Agelidis, R Suryawanshi, D Jaishankar, J Hopkins, ... Science advances 5 (8), eaax0780, 2019 | 60 | 2019 |
| Herpes Simplex Virus 1 Induces Phosphorylation and Reorganization of Lamin A/C through the γ134.5 Protein That Facilitates Nuclear Egress S Wu, S Pan, L Zhang, J Baines, R Roller, J Ames, M Yang, J Wang, ... Journal of virology 90 (22), 10414-10422, 2016 | 55 | 2016 |
| OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection J Ames, T Yadavalli, R Suryawanshi, J Hopkins, A Agelidis, C Patil, ... Nature communications 12 (1), 5401, 2021 | 37 | 2021 |
| Bacterial pigment prodigiosin demonstrates a unique antiherpesvirus activity that is mediated through inhibition of prosurvival signal transducers RK Suryawanshi, L Koujah, CD Patil, JM Ames, A Agelidis, T Yadavalli, ... Journal of Virology 94 (13), 10.1128/jvi. 00251-20, 2020 | 30 | 2020 |
| Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye T Yadavalli, R Suryawanshi, M Ali, A Iqbal, R Koganti, J Ames, VK Aakalu, ... The ocular surface 18 (2), 221-230, 2020 | 20 | 2020 |
| Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing T Yadavalli, R Suryawanshi, R Koganti, J Hopkins, J Ames, L Koujah, ... Science Advances 6 (49), eabd9443, 2020 | 16 | 2020 |
| Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival A Agelidis, BA Turturice, RK Suryawanshi, T Yadavalli, D Jaishankar, ... JCI insight 6 (7), 2021 | 15 | 2021 |
| Intrinsic antiviral activity of optineurin prevents hyperproliferation of a primary herpes simplex virus type 2 infection CD Patil, R Suryawanshi, J Ames, R Koganti, A Agelidis, D Kapoor, ... The Journal of Immunology 208 (1), 63-73, 2022 | 9 | 2022 |
| Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies L Koujah, M Allaham, CD Patil, JM Ames, RK Suryawanshi, T Yadavalli, ... The ocular surface 21, 238-249, 2021 | 9 | 2021 |
| mTORC2 confers neuroprotection and potentiates immunity during virus infection RK Suryawanshi, CD Patil, A Agelidis, R Koganti, JM Ames, L Koujah, ... Nature communications 12 (1), 6020, 2021 | 7 | 2021 |
| Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry RK Suryawanshi, CD Patil, R Koganti, SK Singh, JM Ames, D Shukla Pathogens 10 (7), 803, 2021 | 5 | 2021 |
| Oligodendrocyte-derived IL-33 functions as a microglial survival factor during neuroinvasive flavivirus infection GT Norris, JM Ames, SF Ziegler, A Oberst PLoS Pathogens 19 (11), e1011350, 2023 | 2 | 2023 |
| Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction RK Suryawanshi, CD Patil, A Agelidis, R Koganti, T Yadavalli, JM Ames, ... Science Advances 9 (17), eadf3977, 2023 | 2 | 2023 |
| OPTN limits herpes stromal keratitis severity and demyelination through negative regulation of IL-17 and hyperinflammatory T-cell response J Ames, T Yadavalli, C Patil, J Hopkins, I Bhattacharya, D Shukla BioRxiv, 2021.11. 29.470418, 2021 | 2 | 2021 |
| RIPK3 coordinates RHIM domain-dependent inflammatory transcription in neurons SB Kofman, LH Chu, JM Ames, SD Chavarria, K Lichauco, BP Daniels, ... bioRxiv, 2024.02. 29.582857, 2024 | 1 | 2024 |
| Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform T Yadavalli, J Ames, D Wu, B Ramirez, N Bellamkonda, D Shukla European Journal of Pharmaceutics and Biopharmaceutics 173, 150-159, 2022 | 1 | 2022 |
| mTORC2 combats cellular stress and potentiates immunity during viral infection RK Suryawanshi, CD Patil, A Agelidis, R Koganti, JM Ames, L Koujah, ... bioRxiv, 2020.10. 09.333500, 2020 | 1 | 2020 |
| Exposure of negative-sense viral RNA in the cytoplasm initiates innate immunity to West Nile virus E Genoyer, J Wilson, JM Ames, C Stokes, D Moreno, N Etzyon, A Oberst, ... bioRxiv, 2024.06. 07.597966, 2024 | | 2024 |
